NCT06233708View on ClinicalTrials.gov

Association Between Pre-op Non-Selective Beta-Blockers and Hepatocellular Carcinoma Recurrence Post-Liver Transplant

CompletedOBSERVATIONAL
Enrollment

2,092

Participants

Timeline

Start Date

January 1, 2008

Primary Completion Date

May 31, 2022

Study Completion Date

May 31, 2022

Conditions
Hepatocellular Carcinoma RecurrentHepatocellular Carcinoma
Interventions
DRUG

Non-Selective Beta-Adrenoreceptor Agonists for Systemic Use

Non-selective blocker including Propranolol, Carvedilol PO was prescribed

Sponsors
All Listed Sponsors
collaborator

Korea Health Industry Development Institute

OTHER_GOV

lead

Asan Medical Center

OTHER

NCT06233708 - Association Between Pre-op Non-Selective Beta-Blockers and Hepatocellular Carcinoma Recurrence Post-Liver Transplant | Biotech Hunter | Biotech Hunter